Paeoniflorin inhibits macrophage-mediated lung cancer metastasis

Chinese Journal of Natural Medicines

Volumn 13, Issue 12, 2015, Pages 925-932

  Wu, Qi ^a   Chen, Gang Ling ^b   Li, Ya Juan ^c   Chen, Yang ^b   Lin, Fang Zhen ^b  

^a China Pharmaceutical University   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Alternatively activated macrophages; Lung cancer; Metastasis; Paeoniflorin; Tumor associated macrophages

Indexed keywords

PAEONIFLORIN; RECOMBINANT INTERLEUKIN 4; GLUCOSIDE; INTERLEUKIN 4; TERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LEWIS LUNG CARCINOMA CELL; LUNG METASTASIS; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION INHIBITION; METASTASIS INHIBITION; MOUSE; MTT ASSAY; NONHUMAN; PERITONEUM MACROPHAGE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR XENOGRAFT; ANIMAL; C57BL MOUSE; CELL MOTION; CHEMISTRY; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; HUMAN; IMMUNOLOGY; LUNG NEOPLASMS; MACROPHAGE; METASTASIS; PAEONIA; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GLUCOSIDES; HUMANS; INTERLEUKIN-4; LUNG NEOPLASMS; MACROPHAGES; MICE; MICE, INBRED C57BL; MONOTERPENES; NEOPLASM METASTASIS; PAEONIA;

EID: 84951188327     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(15)30098-4     Document Type: Article

References (20)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics 2012 [J]. CA Cancer J Clin 2015, 65(2):87-108.
2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [J]. Int J Cancer 2015, 136(5):E359-E386.
3. Sampsonas F, Ryan D, McPhillips D, et al. Molecular testing and personalized treatment of lung cancer [J]. Curr Mol Pharmacol 2014, 7(1):22-32.
4. Dimou A, Papadimitrakopoulou V Non-small cell lung cancer beyond biomarkers: The evolving landscape of clinical trial design [J]. J Pers Med 2014, 4(3):386-401.
5. Bonde A-K, Tischler V, Kumar S, et al. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors [J]. BMC Cancer 2012, 12:35.
6. Hanahan D, Coussens LM Accessories to the crime: functions of cells recruited to the tumor microenvironment [J]. Cancer Cell 2012, 21(3):309-322.
7. Qian BZ, Pollard JW Macrophage diversity enhances tumor progression and metastasis [J]. Cell 2010, 141(1):39-51.
8. Na YR, Yoon YN, Son DI, et al. Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model [J]. PLoS One 2013, 8(5):e63451.
9. Chen GL, Su X, Lin FZ, et al. Study on the anti-metastatic effects of paeoniflorin to Lewis lung carcinoma in mice [J]. Pharmacol Clin Chin Mater Med 2013, 3:61-62.
10. Hu S, Sun W, Wei W, et al. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis [J]. Anticancer Drugs 2013, 24(2):140-149.
11. Zhang L, Zhang S Modulating Bcl-2 family proteins and caspase-3 in induction of apoptosis by paeoniflorin in human cervical cancer cells [J]. Phytother Res 2011, 25(10):1551-1557.
12. Wang H, Zhou H, Wang CX, et al. Paeoniflorin inhibits growth of human colorectal carcinoma HT 29 cells in vitro and in vivo [J]. Food Chem Toxicol 2012, 50(5):1560-1567.
13. Chu D, Du M, Hu X, et al. Paeoniflorin attenuates schistosomiasis japonica-associated liver fibrosis through inhibiting alternative activation of macrophages [J]. Parasitology 2011, 138(10):1259-1271.
14. Park KI, Park HS, Kang SR, et al. Korean Scutellaria baicalensis water extract inhibits cell cycle G1/S transition by suppressing cyclin D1 expression and matrix-metalloproteinase-2 activity in human lung cancer cells [J]. J Ethnopharmacol 2011, 113(2):634-641.
15. Zhang B, Wang J, Gao J, et al. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [J]. J Cell Biochem 2009, 107(1):134-143.
16. Komiya Y, Akiyama H, Sakumoto R, et al. FBI1/Akirin2 promotes tumorigenicity and metastasis of Lewis lung carcinoma cells [J]. Biochem Biophys Res Commun 2014, 444(3):382-386.
17. Fujisaka S, Usui I, Bukhari A, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice [J]. Diabetes 2009, 58(11):2574-2582.
18. Koshkina NV, Rao-Bindal K, Kleinerman ES Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases [J]. Cancer 2011, 117(15):3457-3467.
19. Zhang B, Yao G, Zhang Y, et al. M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma [J]. Clinics (Sao Paulo) 2011, 66(11):1879-1886.
20. Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization [J]. Front Biosci 2008, 13:453-461.